Upregulation of PIP3-Dependent Rac Exchanger 1 (P-Rex1) Promotes Prostate Cancer Metastasis

[1]  Dianqing Wu,et al.  Lack of a significant role of P-Rex1, a major regulator of macrophage Rac1 activation and chemotaxis, in atherogenesis. , 2008, Prostaglandins & other lipid mediators.

[2]  N. Demartines,et al.  mTORC2 regulates PGE2-mediated endothelial cell survival and migration. , 2008, Biochemical and biophysical research communications.

[3]  P. Steeg,et al.  Metastasis: a therapeutic target for cancer , 2008, Nature Clinical Practice Oncology.

[4]  A. Smrcka,et al.  Small Molecule Disruption of G Protein βγ Subunit Signaling Inhibits Neutrophil Chemotaxis and Inflammation , 2008, Molecular Pharmacology.

[5]  M. Thelen,et al.  Membrane Translocation of P-Rex1 Is Mediated by G Protein βγ Subunits and Phosphoinositide 3-Kinase* , 2007, Journal of Biological Chemistry.

[6]  J. Gutkind,et al.  P-Rex1 Links Mammalian Target of Rapamycin Signaling to Rac Activation and Cell Migration* , 2007, Journal of Biological Chemistry.

[7]  J. Segall,et al.  Cell Motility and Cytoskeletal Regulation in Invasion and Metastasis , 2007, Journal of Mammary Gland Biology and Neoplasia.

[8]  G. Xiao,et al.  CCR2 expression correlates with prostate cancer progression , 2007, Journal of cellular biochemistry.

[9]  J. Condeelis,et al.  Regulation of the actin cytoskeleton in cancer cell migration and invasion. , 2007, Biochimica et biophysica acta.

[10]  J. Gutkind,et al.  G-protein-coupled receptors and cancer , 2007, Nature Reviews Cancer.

[11]  Baolin Zhang,et al.  Rac signaling in tumorigenesis and as target for anticancer drug development. , 2006, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[12]  M. Schiller Coupling receptor tyrosine kinases to Rho GTPases--GEFs what's the link. , 2006, Cellular signalling.

[13]  M. Simpson,et al.  Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. , 2006, The American journal of pathology.

[14]  John G. Collard,et al.  Prognostic relevance of Tiam1 protein expression in prostate carcinomas , 2006, British Journal of Cancer.

[15]  P. Casey,et al.  A Role for the G12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion* , 2006, Journal of Biological Chemistry.

[16]  Alan V. Smrcka,et al.  Differential Targeting of Gßγ-Subunit Signaling with Small Molecules , 2006, Science.

[17]  Yan Xie,et al.  Regulator of G-protein signaling 2 (RGS2) inhibits androgen-independent activation of androgen receptor in prostate cancer cells , 2006, Oncogene.

[18]  K. Okkenhaug,et al.  P-Rex1 Regulates Neutrophil Function , 2005, Current Biology.

[19]  D. Yamazaki,et al.  Regulation of cancer cell motility through actin reorganization , 2005, Cancer science.

[20]  M. Sone,et al.  Involvement of a Rac Activator, P-Rex1, in Neurotrophin-Derived Signaling and Neuronal Migration , 2005, The Journal of Neuroscience.

[21]  Poonam K Sharma,et al.  Decreased expression of e6-associated protein in breast and prostate carcinomas. , 2005, Endocrinology.

[22]  P. Finan,et al.  Regulation of P-Rex1 by Phosphatidylinositol (3,4,5)-Trisphosphate and Gβγ Subunits* , 2005, Journal of Biological Chemistry.

[23]  H. Klocker,et al.  The importance of the CXCL12-CXCR4 chemokine ligand-receptor interaction in prostate cancer metastasis. , 2004, Journal of experimental therapeutics & oncology.

[24]  J. Gutkind,et al.  P‐REX2, a novel PI‐3‐kinase sensitive Rac exchange factor , 2004, FEBS letters.

[25]  E. Yang,et al.  Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21CIP1 levels in androgen-independent human prostate cancer cells , 2004, Oncogene.

[26]  Yi Zheng,et al.  Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[28]  Meghan E. Minard,et al.  The Role of the Guanine Nucleotide Exchange Factor Tiam1 in Cellular Migration, Invasion, Adhesion and Tumor Progression , 2004, Breast Cancer Research and Treatment.

[29]  Y. Daaka G Proteins in Cancer: The Prostate Cancer Paradigm , 2004, Science's STKE.

[30]  A. Bookout,et al.  Targeting Gβγ Signaling to Inhibit Prostate Tumor Formation and Growth* , 2003, Journal of Biological Chemistry.

[31]  J. Gutkind,et al.  Rac1 Function Is Required for Src-induced Transformation , 2003, Journal of Biological Chemistry.

[32]  F. Mayor,et al.  Signaling pathways for monocyte chemoattractant protein 1-mediated extracellular signal-regulated kinase activation. , 2003, Molecular pharmacology.

[33]  Lewis C Cantley,et al.  The phosphoinositide 3-kinase pathway. , 2002, Science.

[34]  R. Cerione,et al.  Signaling to the Rho GTPases: networking with the DH domain , 2002, FEBS letters.

[35]  H. Bourne,et al.  Gαi Is Not Required for Chemotaxis Mediated by Gi-coupled Receptors* , 1999, The Journal of Biological Chemistry.

[36]  S. Bagrodia,et al.  Cytoskeletal Reorganization by G Protein-Coupled Receptors Is Dependent on Phosphoinositide 3-Kinase γ, a Rac Guanosine Exchange Factor, and Rac , 1998, Molecular and Cellular Biology.

[37]  M. Baggiolini,et al.  Two murine homologues of the human chemokine receptor CXCR4 mediating stromal cell‐derived factor 1α activation of Gi2 are differentially expressed in vivo , 1997, European journal of immunology.

[38]  K. Ching,et al.  Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines , 1993, Molecular and Cellular Biochemistry.

[39]  A. Smrcka,et al.  Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. , 2008, Molecular pharmacology.

[40]  A. Albini,et al.  The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation , 2007, Nature Protocols.

[41]  M. Thelen,et al.  Membrane translocation of P-Rex1 is mediated by G protein betagamma subunits and phosphoinositide 3-kinase. , 2007, The Journal of biological chemistry.

[42]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[43]  Dianqing Wu,et al.  Differential targeting of Gbetagamma-subunit signaling with small molecules. , 2006, Science.

[44]  M. Mimeault,et al.  Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. , 2006, Carcinogenesis.

[45]  P. Finan,et al.  Regulation of P-Rex1 by phosphatidylinositol (3,4,5)-trisphosphate and Gbetagamma subunits. , 2005, The Journal of biological chemistry.

[46]  A. Bookout,et al.  Targeting Gbetagamma signaling to inhibit prostate tumor formation and growth. , 2003, The Journal of biological chemistry.

[47]  P. Hawkins,et al.  P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. , 2002, Cell.

[48]  A. Bex,et al.  Influence of pertussis toxine on local progression and metastasis after orthotopic implantation of the human prostate cancer cell line PC3 in nude mice , 1999, Prostate Cancer and Prostatic Diseases.

[49]  H. Bourne,et al.  Galphai is not required for chemotaxis mediated by Gi-coupled receptors. , 1999, The Journal of biological chemistry.

[50]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.

[51]  B. Pontz,et al.  A study on fibroblast chemotaxis using fibronectin and conditioned medium as chemoattractants. , 1983, European journal of cell biology.